240 related articles for article (PubMed ID: 34268631)
21. Could ZnT8 antibodies replace ICA, GAD, IA2 and insulin antibodies in the diagnosis of type 1 diabetes?
Lounici Boudiaf A; Bouziane D; Smara M; Meddour Y; Haffaf EM; Oudjit B; Chaib Mamouzi S; Aouichat Bouguerra S
Curr Res Transl Med; 2018 Mar; 66(1):1-7. PubMed ID: 29487039
[TBL] [Abstract][Full Text] [Related]
22. Glutamic acid decarboxylase antibody positivity is associated with an impaired insulin response to glucose and arginine in nondiabetic patients with autoimmune thyroiditis.
Lethagen AL; Ericsson UB; Hallengren B; Groop L; Tuomi T
J Clin Endocrinol Metab; 2002 Mar; 87(3):1177-83. PubMed ID: 11889183
[TBL] [Abstract][Full Text] [Related]
23. Insulin intervention to preserve beta cells in slowly progressive insulin-dependent (type 1) diabetes mellitus.
Kobayashi T; Maruyama T; Shimada A; Kasuga A; Kanatsuka A; Takei I; Tanaka S; Yokoyama J
Ann N Y Acad Sci; 2002 Apr; 958():117-30. PubMed ID: 12021091
[TBL] [Abstract][Full Text] [Related]
24. Slowly progressive insulin-dependent (type 1) diabetes positive for anti-GAD antibody ELISA test may be strongly associated with a future insulin-dependent state.
Oikawa Y; Tanaka H; Uchida J; Atsumi Y; Osawa M; Katsuki T; Kawai T; Shimada A
Endocr J; 2017 Feb; 64(2):163-170. PubMed ID: 27760891
[TBL] [Abstract][Full Text] [Related]
25. Japanese cases of acute onset diabetic ketosis without acidosis in the absence of glutamic acid decarboxylase autoantibody.
Iwasaki Y; Hamamoto Y; Kawasaki Y; Ikeda H; Honjo S; Wada Y; Koshiyama H
Endocrine; 2010 Apr; 37(2):286-8. PubMed ID: 20960264
[TBL] [Abstract][Full Text] [Related]
26. Antibodies to glutamic acid decarboxylase in at-risk and clinical insulin-dependent diabetic subjects: relationship to age, sex and islet cell antibody status, and temporal profile.
Schmidli RS; DeAizpurua HJ; Harrison LC; Colman PG
J Autoimmun; 1994 Feb; 7(1):55-66. PubMed ID: 8198702
[TBL] [Abstract][Full Text] [Related]
27. Increased diagnosis of autoimmune childhood-onset Japanese type 1 diabetes using a new glutamic acid decarboxylase antibody enzyme-linked immunosorbent assay kit, compared with a previously used glutamic acid decarboxylase antibody radioimmunoassay kit.
Sugihara S; Yokota I; Mukai T; Mochizuki T; Nakayama M; Tachikawa E; Kawada Y; Minamitani K; Kikuchi N; Urakami T; Kawamura T; Kawasaki E; Kikuchi T; Amemiya S;
J Diabetes Investig; 2020 May; 11(3):594-602. PubMed ID: 31756289
[TBL] [Abstract][Full Text] [Related]
28. [Relation between insulin resistance and glutamic acid decarboxylase antibody titers in latent autoimmune diabetes in adults].
Li X; Huang G; Yan X; Yang L; Zhou ZG
Nan Fang Yi Ke Da Xue Xue Bao; 2010 Jun; 30(6):1247-9. PubMed ID: 20584648
[TBL] [Abstract][Full Text] [Related]
29. Clinical characteristics and autoantibody pattern in newly diagnosed adult-onset autoimmune diabetes.
Paschke A; Grzelka A; Zawada A; Zozulińska-Ziółkiewicz D
Pol Arch Med Wewn; 2013; 123(7-8):401-8. PubMed ID: 23792409
[TBL] [Abstract][Full Text] [Related]
30. Glutamic acid decarboxylase autoantibody-positivity post-partum is associated with impaired β-cell function in women with gestational diabetes mellitus.
Lundberg TP; Højlund K; Snogdal LS; Jensen DM
Diabet Med; 2015 Feb; 32(2):198-205. PubMed ID: 25345799
[TBL] [Abstract][Full Text] [Related]
31. Islet autoantibodies in clinically diagnosed type 2 diabetes: prevalence and relationship with metabolic control (UKPDS 70).
Davis TM; Wright AD; Mehta ZM; Cull CA; Stratton IM; Bottazzo GF; Bosi E; Mackay IR; Holman RR
Diabetologia; 2005 Apr; 48(4):695-702. PubMed ID: 15729570
[TBL] [Abstract][Full Text] [Related]
32. Antibody to the M(r) 65,000 isoform of glutamic acid decarboxylase are detected in non-insulin-dependent diabetes in Japanese.
Kasuga A; Maruyama T; Ozawa Y; Takei I; Falorni A; Lernmark A; Saruta T
J Autoimmun; 1996 Feb; 9(1):105-11. PubMed ID: 8845047
[TBL] [Abstract][Full Text] [Related]
33. Autoimmune markers in slow type 1 diabetes: confrontation to type 1 diabetes.
Desailloud R; Fajardy I; Vambergue A; Prevost G; Pigny P; Fontaine P
Diabetes Metab; 2000 Nov; 26(5):353-60. PubMed ID: 11119014
[TBL] [Abstract][Full Text] [Related]
34. The prevalence and characteristics of latent autoimmune diabetes in adults (LADA) and its relation with chronic complications in a clinical department of a university hospital in Korea.
Roh MO; Jung CH; Kim BY; Mok JO; Kim CH
Acta Diabetol; 2013 Apr; 50(2):129-34. PubMed ID: 20953640
[TBL] [Abstract][Full Text] [Related]
35. Interventions for latent autoimmune diabetes (LADA) in adults.
Brophy S; Brunt H; Davies H; Mannan S; Williams R
Cochrane Database Syst Rev; 2007 Jul; (3):CD006165. PubMed ID: 17636829
[TBL] [Abstract][Full Text] [Related]
36. The clinical characteristics of latent autoimmune diabetes in adults and its relation with chronic complications in metabolically poor controlled Turkish patients with Type 2 diabetes mellitus.
Arikan E; Sabuncu T; Ozer EM; Hatemi H
J Diabetes Complications; 2005; 19(5):254-8. PubMed ID: 16112499
[TBL] [Abstract][Full Text] [Related]
37. Metabolite Profiling of LADA Challenges the View of a Metabolically Distinct Subtype.
Al-Majdoub M; Ali A; Storm P; Rosengren AH; Groop L; Spégel P
Diabetes; 2017 Apr; 66(4):806-814. PubMed ID: 27913577
[TBL] [Abstract][Full Text] [Related]
38. UKPDS 25: autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes. UK Prospective Diabetes Study Group.
Turner R; Stratton I; Horton V; Manley S; Zimmet P; Mackay IR; Shattock M; Bottazzo GF; Holman R
Lancet; 1997 Nov; 350(9087):1288-93. PubMed ID: 9357409
[TBL] [Abstract][Full Text] [Related]
39. Latent autoimmune diabetes in adults (LADA): usefulness of anti-GAD antibody titers and benefit of early insulinization.
Rosário PW; Reis JS; Fagundes TA; Calsolari MR; Amim R; Silva SC; Purisch S
Arq Bras Endocrinol Metabol; 2007 Feb; 51(1):52-8. PubMed ID: 17435855
[TBL] [Abstract][Full Text] [Related]
40. GAD autoantibodies and epitope reactivities persist after diagnosis in latent autoimmune diabetes in adults but do not predict disease progression: UKPDS 77.
Desai M; Cull CA; Horton VA; Christie MR; Bonifacio E; Lampasona V; Bingley PJ; Levy JC; Mackay IR; Zimmet P; Holman RR; Clark A
Diabetologia; 2007 Oct; 50(10):2052-60. PubMed ID: 17657474
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
